Coya Therapeutics, Inc.

COYA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$6-$7-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1,080$0
Change in WC-$1-$1$3-$0
Other Non-Cash$2$1-$3,904$1
Operating Cash Flow-$1-$6-$2,828-$2
Investing Activities
PP&E Inv.-$1$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$10
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$19$0
Financing Cash Flow$0$0$19$10
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$6-$2,809$7
Supplemental Information
Beg. Cash$30$36$38,340$31
End Cash$28$30$35,531$38
Free Cash Flow-$1-$6-$2,828-$2
Coya Therapeutics, Inc. (COYA) Financial Statements & Key Stats | AlphaPilot